NDAINTRAVENOUSSOLUTION
Approved
Dec 2020
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
2/8 — Basic
GALLIUM GA 68 GOZETOTIDE (gallium ga-68 gozetotide) by Francis Medical is positron emitting activity [moa]. First approved in 2020.
Drug data last refreshed 4h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Gallium Ga-68 Gozetotide is a radioactive diagnostic agent administered intravenously that emits positron activity for imaging purposes. It is used to visualize specific molecular targets in patients undergoing positron emission tomography (PET) imaging. The agent helps clinicians detect and localize disease through targeted radiopharmaceutical imaging.
Peak
Product is in peak revenue phase with moderate competitive pressure (30/100), indicating stable market position and ongoing commercial investment opportunities.
Mechanism of Action
Positron Emitting Activity
Pharmacologic Class:
Radioactive Diagnostic Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Gallium Ga-68 Gozetotide offers career exposure to specialized radiopharmaceutical commercialization, healthcare economics, and imaging reimbursement dynamics. The product's peak lifecycle stage suggests stable but potentially plateau-bound career growth, with emphasis on defending market share rather than expansion.
Brand Manager
Worked on GALLIUM GA 68 GOZETOTIDE at Francis Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.